+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Saudi Arabia Healthcare Logistics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2027-2032)

  • PDF Icon

    Report

  • 150 Pages
  • October 2026
  • Region: Saudi Arabia
  • Mordor Intelligence
  • ID: 6294316
The Saudi Arabia healthcare logistics market size is valued at USD 1.96 billion in 2026. It is estimated to grow from USD 2.08 billion in 2027 to reach USD 2.81 billion by 2032, at a CAGR of 6.26% during the forecast period from 2027 to 2032. The Health Sector Transformation Program shapes the Saudi Arabia healthcare logistics market, tighter distribution rules, and pharmaceutical localization. This report is Segmented by Logistics (Transportation, and More), by Temperature (Temperature Controlled, Non- Temperature), by Product (Pharmaceuticals, Cell & Gene Therapies, Vaccines, and More), by Destination (Domestic, International), by End User (Pharmaceutical and Manufacturers, and More), and by Region (Central, Eastern, and More). The Market Forecasts are Provided in Terms of Value (USD).

Saudi Arabia Healthcare Logistics Market Trends and Insights

Vision 2030 Expanding Healthcare Logistics Demand

The Health Sector Transformation Program links healthcare access, infrastructure, and service delivery objectives with larger needs for product movement across Saudi Arabia. NUPCO centrally procures and distributes pharmaceuticals, medical devices, and clinical supplies, creating recurring nationwide flows for the Saudi Arabia healthcare logistics market. Those flows call for dependable movement between suppliers, central distribution points, regional facilities, and care locations. Centralized purchasing puts pressure on routine distribution margins while increasing the value of specialized cold-chain services. E-pharmacy growth and direct supply to hospital departments reinforce the need for providers that can manage shorter delivery windows and verified handoffs. Hub development in Riyadh and Jeddah can support these delivery models by placing controlled facilities closer to major demand points.

SFDA Compliance Strengthening Regulated Distribution Requirements

SFDA requirements cover transport and storage of pharmaceutical products handled through customs ports, including the controls needed to protect product quality. Documented temperature monitoring, traceability, and deviation procedures make compliance systems central to participation in the Saudi Arabia healthcare logistics market. The Drug Track and Trace System requires electronic integration with the national pharmaceutical tracking infrastructure. In October 2025, the SFDA said that technology-enabled monitoring of drug availability supports the country’s health objectives. These requirements favor operators that can demonstrate consistent GDP and GSP processes across clearance, warehousing, and final delivery. They also increase the importance of Arabic documentation, regulatory liaison capability, and audit-ready digital records.

Extreme Heat Increasing Cold-Chain Operating Costs

High summer temperatures create a persistent operating burden for temperature-controlled transport in the Saudi Arabia healthcare logistics market. Refrigeration equipment must maintain the required range during road transit, which increases energy use and maintenance needs. The cost exposure is significant where a temperature excursion can compromise high-value biologics. Providers also need qualified staff who can operate validated refrigeration systems and respond to alarms. This capability is more limited outside Riyadh, Jeddah, and Dammam. The combination of climate conditions and workforce shortages can delay capacity growth even when demand for cold-chain services rises.

Other drivers and restraints analyzed in the detailed report include:

  1. Biologics Growth Increasing Temperature-Controlled Logistics Demand
  2. Pharmaceutical Localization Expanding Domestic Healthcare Supply Chains
  3. Customs Complexity Delaying Imported Healthcare Product Clearance

Segment Analysis

Transportation accounts for 58.67% of the Saudi Arabia healthcare logistics market share in 2026. Road transport supports regular distribution between central warehouses, pharmacies, clinics, and hospitals across the Kingdom. Air freight is used for time-sensitive biologics, urgent clinical materials, and high-value consignments. Warehousing and distribution provide the controlled inventory base needed before downstream deliveries. The Saudi Arabia healthcare logistics market depends on these functions working together because every handoff must protect product integrity.

Value-added services and others are forecast to expand at an 8.89% CAGR through 2032. Pharmaceutical companies increasingly require secondary labeling, Arabic-language documentation, and packaging tailored to the destination market. AJEX opened a GMP-GxP-compliant facility in Riyadh in October 2025 with temperature-controlled chambers and a dedicated labeling room. These facilities enable providers to combine product preparation with validated storage and distribution. This integrated model helps customers reduce the number of compliance-sensitive handoffs before products reach care sites.

Non-temperature controlled logistics accounts for 52.41% of the Saudi Arabia healthcare logistics market in 2026. Ambient-stable medicines, medical devices, and diagnostics account for a substantial volume of products that do not need refrigerated transport. These categories support routine distribution through established road and warehousing networks. Their broad use gives ambient logistics an important role in nationwide healthcare supply. However, the operating requirements become stricter when products require chilled, frozen, or ultra-low-temperature conditions.

Temperature-controlled logistics is projected to register an 8.45% CAGR through 2032. Biologics, vaccine programs, and the emergence of domestic advanced-therapy production are driving this demand. The deep-frozen and ultra-low-temperature tier serves the most demanding requirements, while chilled and frozen services support other pharmaceutical categories. Operators need validated equipment, monitored storage, trained staff, and procedures for responding to excursions. The Saudi Arabia healthcare logistics industry will need additional certified capacity as the treatment mix moves toward products that require verified conditions.

Complete Report Scope:

  • By Logistics Function
    • Transportation
      • Road
      • Air
      • Sea and Inland Waterways
      • Rail
    • Warehousing and Distribution
    • Value-added Services and Others
  • By Temperature Type
    • Temperature Controlled
      • Chilled (0-5 °C)
      • Frozen (-20-0 °C)
      • Ambient
      • Deep-Frozen / Ultra-Low (less than-20 °C)
    • Non-Temperature Controlled
  • By Product Type
    • Pharmaceuticals
      • Prescription and Specialty Drugs
      • OTC Drugs
    • Biopharmaceuticals (Biologics and Biosimilars)
    • Vaccines
    • Clinical Trial Materials
    • Cell and Gene Therapies
    • Medical Devices
    • Veterinary Medicine
    • Blood, Plasma and Blood Components
    • Diagnostic and Laboratory Products
    • Organs and Human Tissues
    • Others
  • By Destination
    • Domestic
    • International
  • By End User
    • Pharmaceutical Manufacturers
    • Biopharmaceutical Manufacturers
    • Hospitals and Clinics
    • Pharmacies (Hospital/Institutional and Retail)
    • Healthcare Distributors and Wholesalers
    • Others
  • By Region
    • Central (Riyadh, Al-Qassim, and Hail)
    • Eastern (Ash-Sharqiyah)
    • Western (Al-Bahah, Makkah, Medina, and Tabuk)
    • Northern (Al-Jouf and Arar)
    • Southern (Asir, Jazan, and Najran)

List of Companies Covered in this Report:

  1. AJEX Logistics Services
  2. Aramex PJSC
  3. BAFCO International Shipping & Logistics Co. Ltd
  4. CEVA Almajdouie Logistics (CMA CGM Group)
  5. DHL Group
  6. DSV A/S (including DB Schenker)
  7. Expeditors International of Washington, Inc.
  8. FedEx Corporation
  9. Four Winds Saudi Arabia Limited
  10. Hellmann Worldwide Logistics
  11. Kuehne+Nagel
  12. Medical Support Logistics Company (MSCT)
  13. Mosanada Logistics Services
  14. Proceed Logistics
  15. SAL Saudi Logistics Services Company
  16. Saudi Post | SPL (including NAQEL Express)
  17. Saudia Cargo
  18. SMSA Express Transportation Company Ltd
  19. Takhzeen Logistics
  20. Tamer Logistics
  21. United Parcel Service, Inc. (UPS Healthcare)
  22. Wared Logistics

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
3.1 Market Size, Growth, and Forecast Outlook
3.2 Key Demand Drivers and Healthcare Logistics Trends
3.3 Major Distribution Hubs and Demand Concentration
3.4 Competitive Landscape and Leading Healthcare Logistics Providers
4 MARKET LANDSCAPE
4.1 Market Overview and Role of Logistics in Healthcare
4.2 Healthcare Spending Trends
4.3 Market Drivers
4.3.1 Vision 2030 Expanding Healthcare Logistics Demand
4.3.2 SFDA Compliance Strengthening Regulated Distribution Requirements
4.3.3 Biologics Growth Increasing Temperature-Controlled Logistics Demand
4.3.4 Pharmaceutical Localization Expanding Domestic Healthcare Supply Chains
4.3.5 E-Pharmacy Growth Increasing Direct-to-Patient Delivery Demand
4.3.6 Logistics Hub Development Strengthening Regional Healthcare Distribution
4.4 Market Restraints
4.4.1 Extreme Heat Increasing Cold-Chain Operating Costs
4.4.2 Customs Complexity Delaying Imported Healthcare Product Clearance
4.4.3 Certified Cold-Chain Talent Shortages Limiting Service Capacity
4.4.4 Remote Last-Mile Economics Increasing Healthcare Distribution Costs
4.5 Regulatory Framework for Healthcare Logistics Operations
4.6 Healthcare Supply Chain and Distribution Network Analysis
4.7 Technology Innovation and Digital Logistics Outlook
4.8 Evolution of Healthcare Logistics Requirements
4.9 Pharmaceutical Distribution Network and Cargo Flow Analysis
4.10 Cold Chain Capacity and Infrastructure Development Analysis
4.11 Healthcare Warehousing and Distribution Hub Network Analysis
4.12 Porter's Five Forces Analysis
4.12.1 Threat of New Entrants
4.12.2 Bargaining Power of Suppliers
4.12.3 Bargaining Power of Buyers
4.12.4 Threat of Substitutes
4.12.5 Rivalry Among Competitors
4.13 Impact of Geo-Political Events on Supply Chain Shifts
5 MARKET SIZE AND GROWTH FORECASTS
5.1 By Logistics Function
5.1.1 Transportation
5.1.1.1 Road
5.1.1.2 Air
5.1.1.3 Sea and Inland Waterways
5.1.1.4 Rail
5.1.2 Warehousing and Distribution
5.1.3 Value-added Services and Others
5.2 By Temperature Type
5.2.1 Temperature Controlled
5.2.1.1 Chilled (0-5 °C)
5.2.1.2 Frozen (-20-0 °C)
5.2.1.3 Ambient
5.2.1.4 Deep-Frozen / Ultra-Low (less than-20 °C)
5.2.2 Non-Temperature Controlled
5.3 By Product Type
5.3.1 Pharmaceuticals
5.3.1.1 Prescription and Specialty Drugs
5.3.1.2 OTC Drugs
5.3.2 Biopharmaceuticals (Biologics and Biosimilars)
5.3.3 Vaccines
5.3.4 Clinical Trial Materials
5.3.5 Cell and Gene Therapies
5.3.6 Medical Devices
5.3.7 Veterinary Medicine
5.3.8 Blood, Plasma and Blood Components
5.3.9 Diagnostic and Laboratory Products
5.3.10 Organs and Human Tissues
5.3.11 Others
5.4 By Destination
5.4.1 Domestic
5.4.2 International
5.5 By End User
5.5.1 Pharmaceutical Manufacturers
5.5.2 Biopharmaceutical Manufacturers
5.5.3 Hospitals and Clinics
5.5.4 Pharmacies (Hospital/Institutional and Retail)
5.5.5 Healthcare Distributors and Wholesalers
5.5.6 Others
5.6 By Region
5.6.1 Central (Riyadh, Al-Qassim, and Hail)
5.6.2 Eastern (Ash-Sharqiyah)
5.6.3 Western (Al-Bahah, Makkah, Medina, and Tabuk)
5.6.4 Northern (Al-Jouf and Arar)
5.6.5 Southern (Asir, Jazan, and Najran)
6 COMPETITIVE LANDSCAPE
6.1 Market Concentration
6.2 Key Strategic Moves
6.3 Market Share Analysis
6.4 Company Profiles (includes Global Level Overview, Market Level Overview, Core Segments, Financials as available, Strategic Information, Geographic Coverage, Products and Services, Recent Developments)
6.4.1 AJEX Logistics Services
6.4.2 Aramex PJSC
6.4.3 BAFCO International Shipping & Logistics Co. Ltd
6.4.4 CEVA Almajdouie Logistics (CMA CGM Group)
6.4.5 DHL Group
6.4.6 DSV A/S (including DB Schenker)
6.4.7 Expeditors International of Washington, Inc.
6.4.8 FedEx Corporation
6.4.9 Four Winds Saudi Arabia Limited
6.4.10 Hellmann Worldwide Logistics
6.4.11 Kuehne+Nagel
6.4.12 Medical Support Logistics Company (MSCT)
6.4.13 Mosanada Logistics Services
6.4.14 Proceed Logistics
6.4.15 SAL Saudi Logistics Services Company
6.4.16 Saudi Post | SPL (including NAQEL Express)
6.4.17 Saudia Cargo
6.4.18 SMSA Express Transportation Company Ltd
6.4.19 Takhzeen Logistics
6.4.20 Tamer Logistics
6.4.21 United Parcel Service, Inc. (UPS Healthcare)
6.4.22 Wared Logistics
7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK
7.1 White-Space Opportunities and Unmet Healthcare Logistics Needs
7.2 High-Potential Healthcare Segments and Growth Opportunities
7.3 Strategic Growth Priorities Across Healthcare Logistics Ecosystem
7.4 Future Market Outlook and Emerging Healthcare Demand Pockets

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AJEX Logistics Services
  • Aramex PJSC
  • BAFCO International Shipping & Logistics Co. Ltd
  • CEVA Almajdouie Logistics (CMA CGM Group)
  • DHL Group
  • DSV A/S (including DB Schenker)
  • Expeditors International of Washington, Inc.
  • FedEx Corporation
  • Four Winds Saudi Arabia Limited
  • Hellmann Worldwide Logistics
  • Kuehne+Nagel
  • Medical Support Logistics Company (MSCT)
  • Mosanada Logistics Services
  • Proceed Logistics
  • SAL Saudi Logistics Services Company
  • Saudi Post | SPL (including NAQEL Express)
  • Saudia Cargo
  • SMSA Express Transportation Company Ltd
  • Takhzeen Logistics
  • Tamer Logistics
  • United Parcel Service, Inc. (UPS Healthcare)
  • Wared Logistics